Suloctidil

Suloctidil was a sulfur-containing aminoalcohol that was brought to market in the early 1970s as a vasodilator by Continental Pharma, a Belgian company.^{[1]: 118–121 [2][3]}

ATC code

• C04AX19 (WHO)

CAS Number

• 54767-75-8 ^Y

PubChem CID

• 5354

ChemSpider

• 571402

Quick facts Clinical data, ATC code ...

Suloctidil

Clinical data
ATC code	C04AX19 (WHO)
Identifiers
IUPAC name 1-[4-(isopropylthio)phenyl]-2-(octylamino)propan-1-ol
CAS Number	54767-75-8 Y
PubChem CID	5354
ChemSpider	571402
UNII	XV1N1XY17K
ChEBI	CHEBI:233445
ChEMBL	ChEMBL588119
CompTox Dashboard (EPA)	DTXSID701017974 DTXSID4045638, DTXSID701017974
ECHA InfoCard	100.053.920
Chemical and physical data
Formula	C20H35NOS
Molar mass	337.57 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O
InChI InChI=1S/C20H35NOS/c1-5-6-7-8-9-10-15-21-17(4)20(22)18-11-13-19(14-12-18)23-16(2)3/h11-14,16-17,20-22H,5-10,15H2,1-4H3 Key:BFCDFTHTSVTWOG-UHFFFAOYSA-N
(verify)

Close

Continental was bought by Monsanto in 1984, primarily on the promise of sales of suloctidil, which was approved in Europe at the time, but not in the US.^[4] However, in 1985 Monsanto halted development and withdrew the drug worldwide following reports of liver toxicity.^[5]: 251